2017 Australasian Viral Hepatitis Elimination Conference
There is an urgent need to increase the number of clinicians able to treat hepatitis B and hepatitis C. Until 1 March 2016, therapy uptake for HCV was slow, due to both hard to reach priority populations and the difficulty and length of the treatment itself. In hepatitis B, many people remain undiagnosed and confusion still exists around the idea of a ‘healthy carrier’, masking the need for monitoring and, in some cases, the prescription of effective therapy.
This is the first time that the Australasian Viral Hepatitis Elimination Conference will be held. It is to be held in the off-year of the Australasian Viral Hepatitis Conference to cater for the educational needs of clinicians and researchers given the major changes that are happening in the sector.
The Committee look forward to welcoming you to Cairns in 2017.
Registration and Abstract Submission to open in March 2017
- Gail Matthews, (Convenor) A/Professor, Kirby Institute, UNSW, Australia
- Nicole Allard, General Practitioner, Doherty, Melbourne, Australia
- David Baker, General Practitioner, East Sydney Doctors, ASHM, Australia
- Jude Byrne, Senior Project Officer AIVL, Canberra, Australia
- Ben Cowie, Associate Professor, Doherty Institute, Melbourne, Australia
- Greg Dore, Head, Viral Hepatitis Clinical Research Program, Kirby Institute,UNSW, Australia
- Joe Doyle, Co-Head, Hepatitis Research, Burnet Institute, Melbourne, Australia
- Jason Grebely, Associate Professor, The Kirby Institute, UNSW, Australia
- Margaret Hellard, Professor, Burnet Institute, Melbourne, Australia
- David Iser, St Vincent's Health Melbourne, Australia
- Jacqui Richmond, Research Fellow / Clinical Nurse Consultant, La Trobe University / Melbourne Health, Australia
- Darren Russell, Cairns Sexual Health Service, Australia
- Alex Thompson, Director of Gastroenterology, St Vincent’s Hospital, Melbourne, Victoria
- Jodie Walton, BBV &STI Education Project Officer, Hepatitis Queensland